Centessa Pharmaceuticals plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2024 | 5 | -$0.42 | -$0.37 | -$0.40 |
| Q3 2024 | 3 | -$0.44 | -$0.44 | -$0.44 |
| Q1 2025 | 4 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2025 | 4 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2025 | 4 | -$0.40 | -$0.40 | -$0.40 |
| Q4 2025 | 4 | -$0.40 | -$0.40 | -$0.40 |
Centessa Pharmaceuticals plc Earnings Date And Information
Centessa Pharmaceuticals plc last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.38 by $0.02. The company had revenue of 0 for the quarter and had revenue of 6.88 M for the year. Centessa Pharmaceuticals plc has generated $-2 earnings per share over the last year ($-1.58 diluted earnings per share) and currently has a price-to-earnings ratio of -11.11. Centessa Pharmaceuticals plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Centessa Pharmaceuticals plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/18/2024 | Q2 2024 | -$0.40 | $0 | $0 | ||
| 05/13/2024 | Q1 2024 | -$0.41 | -$0.38 | 0.03 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.44 | -$0.38 | 0.06 | $6.91 M | |
| 11/13/2023 | Q3 2023 | -$0.46 | -$0.40 | 0.06 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.43 | -$0.26 | 0.17 | $0 | |
| 05/12/2023 | Q1 2023 | -$0.41 | -$0.53 | -0.12 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.48 | -$0.46 | 0.02 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.49 | -$0.57 | -0.08 | $0 | |
| 08/10/2022 | Q2 2022 | -$0.56 | -$0.69 | -0.13 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.70 | -$0.60 | 0.1 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.60 | -$0.68 | -0.08 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.55 | -$0.45 | 0.1 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.66 | -$0.65 | 0.01 | $0 | |
| 03/30/2021 | Q1 2021 | -$2.75 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.22 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.02 | $0 | |||
| 06/29/2020 | Q2 2020 | $0.00 | $0 | |||
| 03/30/2020 | Q1 2020 | $0.00 | $0 |
Centessa Pharmaceuticals plc Earnings: Frequently Asked Questions
-
When is Centessa Pharmaceuticals plc's earnings date?
Centessa Pharmaceuticals plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Centessa Pharmaceuticals plc's earnings conference call?
The conference call for Centessa Pharmaceuticals plc's latest earnings report can be listened to online.
-
How can I read Centessa Pharmaceuticals plc's conference call transcript?
The conference call transcript for Centessa Pharmaceuticals plc's latest earnings report can be read online.
-
How much revenue does Centessa Pharmaceuticals plc generate each year?
Centessa Pharmaceuticals plc (:CNTA) has a recorded annual revenue of $6.88 M.
-
How much profit does Centessa Pharmaceuticals plc generate each year?
Centessa Pharmaceuticals plc (:CNTA) has a recorded net income of $6.88 M. Centessa Pharmaceuticals plc has generated $-1.58 earnings per share over the last four quarters.
-
What is Centessa Pharmaceuticals plc's price-to-earnings ratio?
Centessa Pharmaceuticals plc (:CNTA) has a price-to-earnings ratio of -11.11 and price/earnings-to-growth ratio is 1.13.
